VAERS reports by lot

Merck HPV lot H021861: VAERS reports

73 VAERS reports list lot H021861 as a Merck HPV vaccine, received between 2013-06-17 and 2019-02-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
73
Reports
23%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological4634%
General / Systemic (non-local)2720%
Gastrointestinal2216%
Cardiac / Cardiovascular97%
Musculoskeletal86%
Dermatological (non-injection-site)75%
Injection-site / Local reaction64%
Allergic / Anaphylactic54%
Thrombotic / Hematological21%
Psychiatric / Neuropsychiatric21%
Autoimmune / Immune-mediated11%
Respiratory11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Nevada16
California6
Pennsylvania4
Texas4
Illinois3
New Jersey3
Arizona2
Maryland2
Massachusetts2
Iowa2
Hawaii1
Connecticut1

Reports by month received

2013-063
2013-0710
2013-088
2013-0912
2013-1021
2013-113
2013-121
2014-011
2014-031
2014-041
2014-051
2014-071
2014-081
2014-103
2015-071
2015-111
2015-121
2016-072
2019-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.